GBS and CIDP Explained

Close up of a man holding his hand with nerve pain.

With both GBS and CIDP, the body’s immune system mistakenly attacks the peripheral nerves (the nerves that connect the brain and spinal cord to the body). Over time, nerves lose their ability to send signals to the rest of the body, leading to weakness, numbness, tingling, burning pain, and other nerve-related symptoms – sometimes referred to as demyelinating neuropathy. Conditions like Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) are both peripheral disorders; however, they have different symptoms and progression timelines. Understanding these differences is the first step toward managing symptoms, regaining strength, and finding treatments that help you regain your everyday life.

How Does Autoimmune Peripheral Neuropathy Work?

Autoimmune diseases occur when the body’s immune system mistakenly attacks healthy tissues. With peripheral neuropathy, the immune system attacks the peripheral nerves outside the brain and spinal cord. This can lead to numbness, tingling, or pain in the hands and feet. Over time, the damage to these nerves can affect mobility, balance, and everyday function.

What is GBS?

Guillain-Barré Syndrome (GBS) is a rare, autoimmune condition that develops rapidly, often over a few hours, days, or weeks. It can cause sudden weakness, tingling, numbness, or even temporary paralysis, and in severe cases, difficulty breathing. The first signs of GBS can start with muscle weakness and/or tingling sensations. Symptoms usually affect both sides of your body and begin in your feet and legs and spread up to your arms and face. The severity of GBS can range from very mild to severe. Depending on the severity of the condition, other symptoms may include deep muscular pain in your back and/or legs, paralysis of your legs, arms and/or facial muscles and in severe cases, you may experience near-total paralysis. Chest muscle weakness can also occur, which can make it difficult to breathe. This affects about 1 in 3 people with GBS. Symptoms also include difficulty speaking and swallowing, and difficulty moving your eyes and vision issues. While the exact cause of GBS is unknown, in approximately two-thirds of cases, the condition is preceded by an infection within six weeks before symptoms begin. Infections can include respiratory, gastrointestinal, the Zika virus, or COVID-19. With treatment, most people fully recover from the condition.

What is CIDP?

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, long-term autoimmune condition that slowly develops over at least 8 weeks with symptoms such as weakness, numbness, tingling, and fatigue. It typically affects the muscles on both sides of your body in the hips and thighs, shoulders and upper arms, hands, and feet. Other symptoms may include loss of muscle mass in affected muscles, tingling, prickliness, or numbness in your fingers and toes, difficulties with balance and coordination, loss of mobility, loss or weakening of deep tendon (muscle stretch) reflexes, and nerve pain. It can also improve and come back (relapse) over the course of months or years. Unlike GBS, CIDP is ongoing, meaning patients often need regular treatments to calm the immune system and prevent relapses.

GBS vs. CIDP: Key Differences

While both GBS and CIDP involve the immune system attacking the nerves, they differ in important ways.

	GBS	CIDP
Onset	Progresses quickly over hours, several days or weeks, often after an infection	Develops slowly over ≥ 8 weeks. CIDP can come and go over time.
Duration	This condition is usually a one-time event. Symptoms peak quickly and get better over weeks to months.	This condition is long-term and often requires ongoing therapy.
Monitoring	Requires close monitoring during acute phases, typically in the hospital to watch for rapid weakness or breathing problems.	Requires continuous evaluations and possible treatment adjustments.
Treatment Goals	Stop the autoimmune attack on the nerves, manage acute symptoms, prevent complications, and support recovery.	Control the immune system, manage long-term symptoms, prevent relapse, and maintain quality of life.

Treating GBS and CIDP with Immunoglobulin Therapy

IVIg and SCIg therapy are common treatments used for CIDP, while IVIg is used for GBS. IVIg and SCIg can lessen your immune system’s attack on your nerves and support recovery.

For GBS patients, getting Immunoglobulin (Ig) treatment early can slow nerve damage progression and improve recovery.
For CIDP patients, regular Immunoglobulin (Ig) therapy can help maintain function and prevent relapses.

Frequently asked questions about GBS & CIDP

What triggers GBS and CIDP?

GBS is often preceded by an infection in the weeks before symptoms begin. This can include respiratory, gastrointestinal, or viral infections. CIDP usually has no identifiable trigger. The exact cause of both remains unknown, but both are understood as autoimmune responses attacking the peripheral nerves.

Is CIDP a lifelong condition?

CIDP is a long-term condition, but it can be managed. Many people need ongoing therapy to calm the immune system and prevent relapses. With consistent treatment, remission is possible, and early recognition helps prevent lasting disability.

Is GBS contagious?

No, GBS can’t spread from person to person. What is contagious is the preceding infection, not GBS itself. GBS is the immune system’s own response to the infection, attacking the peripheral nerves instead of clearing once the infection goes away.

Can you get immunoglobulin therapy for CIDP at home?

Yes, many people with CIDP receive IVIg or SCIg at home rather than in a hospital or infusion center. Home infusion can be used for maintenance therapy because CIDP treatment is long-term and predictable, and eligibility depends on your clinical stability and your insurance plan.

Live Confidently with GBS or CIDP

Autoimmune neuropathies like GBS and CIDP may share some similarities; however, understanding how they differ is an important step to getting the right care and support. At CSI Pharmacy, we specialize in helping patients living with chronic and rare conditions access safe and effective Ig therapy at home. If you or someone you love is living with GBS or CIDP, contact us today to learn more about IVIg or SCIg for autoimmune neuropathy.

Home Infusion Nurse Visiting Elderly Man for Checkup and Support.

Alpha-1 Antitrypsin Deficiency (AATD): Home Infusion & Treatment Guide

Alpha-1 antitrypsin deficiency (AATD) is a rare condition that primarily affects the lungs, and in some people, the liver. It can lead to shortness of breath or frequent lung infections. While there’s no cure, early diagnosis and treatment can help slow lung damage, manage symptoms, and help many people continue doing the things they enjoy. […]

Patient advocacy team speaking with a patient at a rare disease event.

A Guide to Patient Advocacy in Ig Therapy

Patient advocacy plays an important role in a patient’s Immunoglobulin (Ig) therapy journey, making sure they receive the education and resources to feel confident throughout their treatment journey. Patient advocacy in Ig therapy involves guiding individuals through the complexities of their condition, helping them understand their treatment options, and connecting them with the community and support they deserve. These specialized services offer education and support tailored to each patient’s unique needs. In this guide, we’ll explain what patient advocacy is, why patient advocacy matters […]

Travel Tips for Patients on Immunoglobulin (Ig) Therapy

Planning a trip when you’re managing a rare or chronic condition may feel overwhelming, especially when your treatment schedule feels set in stone. If you’re on immunoglobulin (Ig) therapy and wondering whether travel is even possible, you’re in the right place. In this article, we’ll walk you through everything you need to know to plan your next trip, from coordinating with your specialty pharmacy to navigating medication […]

Preparing Your Child for Ig Therapy: Tips for Parents

Kids are remarkably adaptable, and with the right preparation, immunoglobulin (Ig) therapy can become a familiar, manageable part of your child’s routine. The techniques that make the biggest difference aren’t complicated; they’re small, intentional choices that help your child feel safe and comfortable throughout their Ig infusion. Whether your child is just starting Ig therapy or you’re looking for ways to make ongoing immunoglobulin treatments easier, these tips can make […]

In This Article